Alchemab lands £25m from British Business Bank in record life sciences bet
AI Today Summary
Cambridge-based biotech company Alchemab Therapeutics has secured a £25 million investment from the British Business Bank, marking the lender's largest support for a life sciences firm. The funding will enable Alchemab to expand its extensive antibody sequence database and advance its drug pipeline, including clinical development of therapies for difficult diseases such as ALS. This investment increases Alchemab's total Series A funding to £109 million and supports its AI-driven platform for aut
Covered by 1 source
AI Today publishes original summaries and links out — never the full source article.